-
With Avidity and Pfizer, gene therapy enters a phase
13 Jun 2024 16:57 GMT
… Meghana today! Some gene therapy talk: Pfizer’s gene therapy for Duchenne muscular dystrophy … . Although they cost millions, gene therapies can vastly improve patient lives … Therapeutics and its immunotherapy for lung cancer, mostly to illustrate why survival …
-
Around the Helix: Cell and Gene Therapy Company Updates – June 5, 2024
05 Jun 2024 22:47 GMT
… gene therapies, including partnerships, pipeline updates, and more.
Have a cell and gene therapy … with non–small cell lung cancer (NSCLC) who was … Indian cell and gene therapy company ImmunoAdoptive Cell … recombinant AAVs for gene therapy products. NBX-HEK293 …
-
Lung cancer therapeutics market to grow by $10.52b until 2028
29 May 2024 10:59 GMT
… period.
The global market for lung cancer therapeutics is expected to grow … rising lung cancer prevalence, research is ongoing to develop regenerative therapies, including gene therapies … are considered risk factors for lung cancer.
-
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition
16 May 2024 12:05 GMT
… the 5th International Cell & Gene Therapy China Summit & Exhibition (CGCS … therapy, innovative cell therapy, AAV gene therapy, affordability of CGT, global cooperation … inhibitor-resistant non-small cell lung cancer.
The presentation will also include …
-
Genprex doses first patient in Acclaim─3 study of Reqorsa Immunogene Therapy in combo with Tecentriq to treat small cell lung cancer
15 May 2024 13:09 GMT
… Inc., a clinical-stage gene therapy company focused on developing life … in our fight against lung cancers as we work to … especially aggressive form of lung cancer that has extremely limited … is a clinical-stage gene therapy company focused on developing life …
-
Krystal Biotech: VYJUVEK's Blockbuster Potential In Gene Therapy For DEB
15 May 2024 12:36 GMT
… specializes in developing multidose gene therapy indicated for severe, rare … is a topical gene therapy that requires repeated weekly … barrier formation. The gene therapy candidate KB105 targets these … inhaled KB707 focuses on lung tumors. KB707 received Fast …
-
Genprex dosing subjects in trial of combination therapy for small-cell lung cancer
15 May 2024 09:10 GMT
US-based gene therapy company Genprex has enrolled and … for extensive-stage small cell lung cancer (ES-SCLC).
The Acclaim-3 … study in non-small cell lung cancer enabled us to shorten the … half of 2024.”
Cell & Gene Therapy coverage on Clinical Trials Arena …
-
Clinical Trials Commenced for Immunogene Therapy: Advancing Small Cell Lung Cancer Treatment : Genprex; NASDAQ: GNPX
14 May 2024 14:54 GMT
… 47;gnpx/
Gene Therapy Focused on Life-Changing … its pipeline of gene therapies in order to … aggressive form of lung cancer that has extremely limited … Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers …
-
Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer
14 May 2024 16:42 GMT
… NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life … in our fight against lung cancers as we work to … especially aggressive form of lung cancer that has extremely limited … further its pipeline of gene therapies in order to provide …
-
New Company Officers Appointed After Promising Preclinical Data on Gene Therapy for Anti-Tumor Mechanisms :NASDAQ: GNPX
13 May 2024 14:21 GMT
… Preclinical Results in Cancer Gene Therapy: Genprex, Inc. ( … its pipeline of gene therapies in order to … Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers … energy metabolism in lung cancer cells with opposite …